Internal Medicine, Rheumatology · Durham, NC
NPI
1043394901
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2222 E Nc Highway 54 Ste 200
Durham, NC, 27713
Phone (919) 405-2040
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
309,185 services
Medicare patients, 2024
581
Average age 73
Drug cost, 2024
$6.3M
4,583 prescriptions
Company payments, 2025
$19K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph C Shanahan was code J3262 (injection, tocilizumab, 1 mg), 155,250 times for 27 patients. In total Joseph C Shanahan billed 309,185 services in 44 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 155,250 | 27 | $4.71 | $732K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 55,200 | 57 | $8.95 | $494K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 14,700 | 12 | $8.57 | $126K |
| J0897 Injection, denosumab, 1 mg | Office | 8,760 | 89 | $20.54 | $180K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,800 | 12 | $24.96 | $95K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 920 | 11 | $0.10 | $92.54 |
| 96413 Chemotherapy Administration | Office | 861 | 135 | $87.08 | $75K |
| 99214 Office E&M - Established | Office | 780 | 452 | $89.02 | $69K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 733 | 396 | $11.61 | $8,514 |
| 96401 Chemotherapy Administration | Office | 552 | 114 | $49.98 | $28K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 530 | 12 | $0.23 | $120 |
| 99215 Office E&M - Established | Office | 253 | 171 | $125.79 | $32K |
| 96361 Intravenous Infusion, Hydration | Office | 222 | 31 | $9.00 | $1,997 |
| 96415 Chemotherapy Administration | Office | 128 | 30 | $18.97 | $2,429 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 112 | 31 | $0.51 | $57.02 |
By year: 2022 $3.6M for 277,596 services; 2023 $3.7M for 291,093 services; 2024 $2.9M for 309,185 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph C Shanahan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 563 prescriptions and refills. In total Joseph C Shanahan wrote 4,583 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 563 | 1,405 | 159 | $22K |
| Prednisone Generic | 518 | 692 | 187 | $2,009 |
| Methotrexate Methotrexate Sodium | 385 | 937 | 111 | $12K |
| Allopurinol Generic | 249 | 704 | 73 | $3,067 |
| Humira(Cf) Pen Adalimumab | 158 | 176 | 20 | $1.7M |
| Xeljanz Xr Tofacitinib Citrate | 132 | 132 | 12 | $767K |
| Leflunomide Generic | 127 | 288 | 36 | $8,000 |
| Celecoxib Generic | 92 | 162 | 33 | $3,195 |
| Tramadol Hcl Generic | 73 | 73 | 16 | $387 |
| Alendronate Sodium Generic | 72 | 157 | 22 | $665 |
| Zolpidem Tartrate Generic | 72 | 80 | Under 11 | $317 |
| Mycophenolate Mofetil Generic | 66 | 126 | 17 | $7,641 |
| Colchicine Generic | 64 | 143 | 24 | $8,832 |
| Otezla Apremilast | 63 | 63 | Under 11 | $305K |
| Gabapentin Generic | 63 | 97 | 24 | $814 |
Brand drugs: - claims; generic drugs: 3,573 claims; opioid claims: 185.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph C Shanahan $19K ($19K in general payments such as food, travel and fees) from 19 companies. The largest payer was GlaxoSmithKline, LLC. with $12K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 14 | $12K |
| Lilly USA, LLC LLY | 9 | $3,300 |
| Janssen Biotech, Inc. JNJ | 4 | $2,372 |
| Abbvie Inc. ABBV | 27 | $429 |
| Amgen Inc. AMGN | 35 | $371 |
| Mallinckrodt Hospital Products Inc. | 2 | $168 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $117 |
| Sobi, Inc SOBI.ST | 1 | $106 |
| Genzyme Corporation SNY | 3 | $92.37 |
| Fresenius Kabi USA, LLC | 2 | $63.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.